Status:
RECRUITING
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
Lead Sponsor:
Mayo Clinic
Conditions:
Interstitial Lung Disease
Eligibility:
All Genders
18+ years
Brief Summary
To develop a repository of blood samples from patients with ILD to support future studies into the development of such biomarkers. Patients with pneumonia and healthy patients will also be recruited a...
Detailed Description
The proposed biospecimen repository would be derived from patients diagnosed with ILD. This is to include 500 patients in the repository, with each patient contributing one blood sample. Patients with...
Eligibility Criteria
Inclusion
- Patients with a diagnosis of ILD or any fibrotic disease of the lung or a diagnosis of pneumonia
- Patients willing to provide written informed consent
Exclusion
- Unwillingness/unable to give blood samples
Key Trial Info
Start Date :
August 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2028
Estimated Enrollment :
635 Patients enrolled
Trial Details
Trial ID
NCT03478826
Start Date
August 1 2018
End Date
January 1 2028
Last Update
April 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic
Rochester, Minnesota, United States, 55905